Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on December 3, 2008
J Am Soc Nephrol 20: 405-415, 2009
© 2009 American Society of Nephrology
doi: 10.1681/ASN.2008020227

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2008020227v1
20/2/405    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, Y.-S.
Right arrow Articles by Tarng, D.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, Y.-S.
Right arrow Articles by Tarng, D.-C.

CLINICAL RESEARCH

GST M1 Polymorphism Associates with DNA Oxidative Damage and Mortality among Hemodialysis Patients

Yi-Sheng Lin*, Szu-Chun Hung{dagger}, Yau-Huei Wei{ddagger} and Der-Cherng Tarng§,||

* Division of Nephrology, Taipei City Hospital Zhongxiao Branch, {dagger} Division of Nephrology, Buddhist Tzu Chi Hospital Taipei Branch, and Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, and § Department and Institute of Physiology, || Institute of Clinical Medicine, and {ddagger} Department of Biochemistry and Center for Cellular and Molecular Biology, National Yang-Ming University, Taipei, Taiwan

Correspondence: Dr. Der-Cherng Tarng, Department and Institute of Physiology, National Yang-Ming University and Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan. Phone: +886-2-2826-7080; Fax: +886-2-2826-4049; E-mail: dctarng{at}vghtpe.gov.tw

Received for publication February 25, 2008. Accepted for publication August 26, 2008.

Leukocyte 8-hydroxy-2'-deoxyguanosine (8-OHdG) is a surrogate marker of oxidant-induced DNA damage in patients undergoing maintenance hemodialysis (MHD). Glutathione S-transferase M1 (GST M1) is a member of the GST family of proteins, which protect cellular DNA against oxidative damage. This study tested the association of a common GST M1 gene polymorphism [GST M1(–)], known to produce a dysfunctional enzyme, with levels of 8-OHdG in peripheral blood leukocytes and all-cause mortality among MHD patients. Among 488 MHD patients and 372 gender-matched healthy subjects, the frequency of the GST M1(–) genotype was 63.1 and 60.2%, respectively. The GST M1(–) genotype was associated with significantly higher levels of leukocyte 8-OHdG compared with the GST M1(+) genotype, even after adjustment for potential confounders (P < 0.001). Moreover, GST M1(–) patients who also had a common polymorphism in the DNA repair enzyme 8-oxoguanine DNA glycosylase 1 or who underwent dialysis with a bioincompatible cellulose membrane had the highest median levels of leukocyte 8-OHdG. Multivariate Cox regression revealed that among MHD patients, GST M1(–) genotype approximately doubled the risk for all-cause mortality (hazard ratio 2.24; 95% confidence interval 1.30 to 4.51) during the mean follow-up of 34 mo. In conclusion, patients without GST M1 activity are more vulnerable to oxidative stress and are at greater risk for death compared with those who possess GST M1 activity.







HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP